Safety and innovation go hand-in-hand.
To push the frontier in veterinary biologics, we combine species-specific knowledge with validated drug targets.
We are developing several programs for best-in-class veterinary biologics.
Our robust R&D platform enables cost-effective discovery and development of biologics. Our pipeline addresses a range of prevalent diseases in companion animals such as cancers, autoimmunity and infections.
Oncology
Felis catus
Autoimmunity
Felis catus
Infection
Metabolism
Multiple species
Felis catus
Our state-of-the-art drug discovery and development programs don’t require animal experiments.
We tailor advanced therapies to beloved species using molecular and data science.